Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Pocket-Sized AI ultrasound spot hip problems in newborns?

NCT ID NCT07794644

Diagnosis Sponsor: Murdoch Childrens Research Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time

Summary

This pilot study tests a handheld, AI-powered ultrasound device to screen newborns for developmental dysplasia of the hip, a condition where the hip joint doesn't form properly. Researchers will scan babies before they leave the hospital and compare those results with a standard diagnostic ultrasound at 6 weeks of age. The study also asks caregivers about their experience and tracks how many babies complete the follow-up scan. The goal is to see if this portable method could work for larger screening programs in birthing hospitals.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Artificial intelligence augmented ultrasound device (Exo Iris handheld probe)
What this could lead to
If the AI ultrasound proves accurate and practical, it could enable earlier, easier screening for hip dysplasia in newborns, potentially reducing the need for late diagnoses and complex treatments.
What could go wrong
This is a small pilot study focused on feasibility, not proof of effectiveness. The AI scan may not match the accuracy of standard diagnostic ultrasound, and technical or practical issues could limit its use in hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Enrolled in the Victorian Hip Dysplasia Registry (VicHip) study 2. Infant born at term (≥37 weeks gestation) 3. Infant and caregiver admitted to the post-natal ward 4. Caregivers indicate they are willing to attend a 6-week ultrasound 5. Caregivers can provide a signed and dated informed consent form and is a legally acceptable representative capable of understanding the informed consent document and providing consent on the infant's behalf. Exclusion Criteria: 1. Any known congenital anomalies in the infant precluding examination of the hips 2. Any known congenital neuromuscular conditions in the infant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Developmental dysplasia of hip are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

developmental dysplasia of the hip Hip Dislocation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Developmental dysplasia of hip

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.